Age-based treatment differences in and reluctance to treating older adults with systemic antipsoriatic therapy – a mixed-method pilot study
Background Evidence-based guidance in older adults (≥65 years) with psoriasis is sparse and undertreatment might be present. Objectives To assess prescribing patterns, comfort levels, barriers and needs of dermatologists when treating older adults with systemic antipsoriatic therapy. Methods A mixed...
Main Authors: | Elke L. M. ter Haar, Marcia Tummers, Ewald M. Bronkhorst, Peter C. M. van de Kerkhof, Elke M. G. J. de Jong, Satish F. K. Lubeek |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-10-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2022.2089330 |
Similar Items
-
Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study
by: Elke L.M. ter Haar, et al.
Published: (2022-10-01) -
Antipsoriatic Potential of Quebecol and Its Derivatives
by: Corinne Bouchard, et al.
Published: (2022-05-01) -
Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups
by: Marieke E.C. Winden, et al.
Published: (2020-07-01) -
eHealth Technologies as an intervention to improve adherence to topical antipsoriatics: a systematic review
by: Mathias Tiedemann Svendsen, et al.
Published: (2018-02-01) -
Exploring the potential of nanocarriers in antipsoriatic therapeutics
by: Mohammad Shaif, et al.
Published: (2022-10-01)